Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec
- Status
- COMPLETED
- Phase
- PHASE1
Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes
- Status
- COMPLETED
- Phase
- N/A
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors
- Status
- COMPLETED
- Phase
- N/A
Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients
- Status
- COMPLETED
- Phase
- PHASE4
Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily
- Status
- COMPLETED
- Phase
- PHASE3
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Early Intervention With the Marte Meo Method
- Status
- COMPLETED
- Phase
- NA
A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
- Status
- COMPLETED
- Phase
- PHASE4